好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Regional Cortical Demyelination Predicts Word-Finding Difficulty in Early Multiple Sclerosis
Multiple Sclerosis
S8 - Multiple Sclerosis: Imaging, Biomarkers, and Environmental Exposures (4:42 PM-4:54 PM)
007

To identify whether cortical lesions in regions known to be important for language are associated with language deficits in people with multiple sclerosis (pwMS).

Language deficits are common in pwMS, with word-finding difficulty being the most frequent language complaint in early disease, yet the mechanism for this impairment is unclear. Cortical lesions are common in MS, and recent evidence suggests that cortical lesions may frequently occur in regions implicated in language function.

45 people with relapsing-remitting MS within one year of diagnosis underwent 7T brain MRI and cognitive testing, including a validated task of lexical retrieval speed/word finding. Cortical lesions were identified manually on 0.5mmT1 and T2* weighted images. 7T T1 weighted images were segmented into cortical parcels according to the Human Connectome Project brain atlas, and for each participant, cortical lesions were mapped to individual parcels. Group comparisons were used to identify associations between lesion presence and language impairment. Cortical parcels of interest were chosen based on previously identified regions implicated in language processing.

The analyzed cohort included 32 women and 13 men, mean time since diagnosis 0.6 ± 0.4 years, mean age 34 ± 8 years. Cortical lesions were identified in 38/45 (84%), with 26/45 (58%) having cortical lesions in regions implicated in language function. Degree of demyelination within a superior cortical subnetwork involved in semantic processing predicted slower lexical retrieval speed after controlling for sex, age, total white matter lesion volume, total cortical lesion volume, and premorbid intelligence as measured by the Weschler Test of Adult Reading (WTAR) (log1p OLS β = 24.54, p = 0.022; permutation p = 0.010). Neither total cortical lesion volume nor total white matter lesion volume were significantly associated with performance on any language task.

In early MS, cortical lesions in language regions may be important contributors to expressive language deficits.

Authors/Disclosures
Madeline Cheshire
PRESENTER
Ms. Cheshire has nothing to disclose.
Emma Dereskewicz Ms. Dereskewicz has nothing to disclose.
Batuhan Ayci, MD (Istanbul University-Cerrahpasa) Mr. Ayci has nothing to disclose.
Jonadab Dos Santos Silva, MD, PhD Dr. Dos Santos Silva has nothing to disclose.
Qingying Feng Miss Feng has nothing to disclose.
Julia Galasso Ms. Galasso has nothing to disclose.
Francesco La Rosa, PhD Dr. La Rosa has nothing to disclose.
James F. Sumowski (Icahn School of Medicine At Mount Sinai) Mr. Sumowski has nothing to disclose.
Erin S. Beck, MD (Icahn School of Medicine at Mount Sinai) Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care.